Six Steps To Benefit-Risk Assessment
You may also be interested in...
PhRMA Testing Pilot Framework For Structured Benefit-Risk Assessment
The Pharmaceutical Research and Manufacturers of America’s Benefit-Risk Action Team expects to complete pilot testing of a framework for conducting benefit-risk assessments by the end of 2011.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.